GlassScriptPhysician profile
Ashley N Ward
NPI 1841738606
$3,740.94
in general payments reported to CMS, 2019-2025
23 companies · $707 in 2025
The $707 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $485 · 2023: $936 · 2024: $799 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,389 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,388.64 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $793.21 | 2021-2025 | |
| Genzyme Corporation | $617.17 | 2021-2025 | |
| Alk-Abello, INC | $425.82 | 2021-2025 | Grastek, Ragwitek, Odactra |
| Regeneron Healthcare Solutions, INC. | $338.09 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $269.04 | 2021-2025 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $194.42 | 2021-2025 | Cuvitru, Hyqvia |
| Csl Behring | $173.86 | 2022-2024 | Kcentra, Haegarda |
| Acclarent, INC | $157.46 | 2021-2023 | Relieva Spinplus, Trudi Nav Cable |
| Kaleo, INC. | $133.61 | 2021-2024 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $94.50 | 2022-2025 | Tezspire, Fasenra |
| Blueprint Medicines Corporation | $92.72 | 2024-2025 | Ayvakit |
| Sanofi-Aventis U.S. LLC | $74.02 | 2021-2024 | |
| Stryker Corporation | $73.52 | 2021-2025 | Scopis Ent |
| Amgen INC. | $47.55 | 2021-2024 | Tezspire |
| Smith+Nephew, INC. | $44.98 | 2021-2023 | Coblation, Tula |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $40.10 | 2025 | Xhance |
| Inspire Medical Systems, INC. | $36.31 | 2023 | Inspire |
| Medtronic, INC. | $35.66 | 2021 | |
| Aimmune Therapeutics, INC. | $25.87 | 2022 | |
| Genentech USA, INC. | $22.37 | 2024 | Xolair |
| Bsn Medical INC | $22.35 | 2022 | |
| Convatec INC. | $14.55 | 2021 | |
| Sanofi Pasteur INC. | $13.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.